Now approved
For acute and maintenance treatment of schizophrenia
Rethink the way you treat

New Once-Monthly Invega Sustenna

Brand name: Invega Sustenna
Generic name/category: paliperidone palmitate, atypical antipsychotic
Company: Janssen
Country/Market: USA, North America
Indication(s)/use: acute and maintenance treatment of schizophrenia in adults
Target: Healthcare Professionals (HCP)
Tagline: Rethink the way you treat
Medium: Print ad
Size/duration: Double-page spread
Publication/Aired: Psychiatric Services – November 2009

To see all of this brand's ads on AdPharm, click here

Click here to see the details and full-size version of this ad on AdPharm

AdPharm is the largest online pharmaceutical advertising gallery. It is subscription-based with various subscriptions plans available here.